Ms. Bobo serves as Corporate Vice President of Strategy & Corporate Development at Edwards Lifesciences Corporation, a global leader in patient-focused innovations for structural heart disease. In this role, she oversees the company's long-term strategic planning, mergers and acquisitions, alliance partnerships, and business development initiatives, driving sustainable growth and expansion into emerging markets. Her leadership has been pivotal in aligning Edwards' portfolio with evolving healthcare trends, including transcatheter therapies and digital health solutions. With more than 20 years of experience in healthcare strategy and investment, Ms. Bobo previously served as Vice President of Corporate Development at a leading medical device firm, where she orchestrated over $2 billion in acquisitions and joint ventures that accelerated revenue growth by 35% annually. Earlier in her career, she held consulting roles at McKinsey & Company, advising Fortune 500 medtech clients on market entry and portfolio optimization, and began as an investment banker at J.P. Morgan, focusing on healthcare transactions. She holds an MBA from Harvard Business School and a BS in Biomedical Engineering from Johns Hopkins University. Under Ms. Bobo's guidance, Edwards has successfully executed high-impact deals, such as strategic acquisitions enhancing its structural heart franchise, and forged key partnerships that bolstered R&D pipelines. Recognized as a top executive in healthcare strategy by Forbes and MedTech Dive, she continues to champion data-driven innovation, positioning Edwards for leadership in the $50 billion structural heart market.